MiR-SNPs as Markers of Toxicity and Clinical Outcome in Hodgkin Lymphoma Patients

PLoS ONE - United States
doi 10.1371/journal.pone.0064716
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Late Radiation Toxicity in Hodgkin Lymphoma Patients: Proton Therapy's Potential

Journal of Applied Clinical Medical Physics
InstrumentationNuclear MedicineRadiologyRadiationImagingMedicine
2015English

Differences in Outcome of Patients With Syncytial Variant Hodgkin Lymphoma Compared With Typical Nodular Sclerosis Hodgkin Lymphoma

Therapeutic Advances in Hematology
Hematology
2016English

Clinical Presentation and Outcome in Patients of Over 75 Years Old With Malignant Lymphoma—Clinical Presentation and Outcome in Elderly Lymphoma Patients

International Journal of Clinical Medicine
2011English

Upfront Ahsct in Non Hodgkin Lymphoma-Better Outcome?

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Pulmonary Toxicity in Paediatric Patients With Relapsed or Refractory Hodgkin Lymphoma Receiving Brentuximab Vedotin

British Journal of Haematology
Hematology
2018English

Clinical Characteristics and Treatment Outcomes of Pediatric Patients With Non-Hodgkin Lymphoma in East Asia

Cancer Research and Treatment
Cancer ResearchOncology
2020English

Modulation of Cardiovascular Toxicity in Hodgkin Lymphoma: Potential Role and Mechanisms of Aerobic Training

Future Cardiology
Molecular MedicineCardiovascular MedicineCardiology
2015English

Assessment of Clinical Immunogenicity of Inotuzumab Ozogamicin in Patients With Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia

AAPS Open
2018English

Interim FDG-PET Does Not Predict Outcome in Advanced-Stage Hodgkin Lymphoma Patients Treated With BEACOPP

British Journal of Haematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy